These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 28131754
1. Stability of an ophthalmic micellar formulation of cyclosporine A in unopened multidose eyedroppers and in simulated use conditions. Chennell P, Delaborde L, Wasiak M, Jouannet M, Feschet-Chassot E, Chiambaretta F, Sautou V. Eur J Pharm Sci; 2017 Mar 30; 100():230-237. PubMed ID: 28131754 [Abstract] [Full Text] [Related]
2. Stability of an ophthalmic formulation of polyhexamethylene biguanide in gamma-sterilized and ethylene oxide sterilized low density polyethylene multidose eyedroppers. Bouattour Y, Chennell P, Wasiak M, Jouannet M, Sautou V. PeerJ; 2018 Mar 30; 6():e4549. PubMed ID: 29682408 [Abstract] [Full Text] [Related]
3. Physicochemical Stability of a Novel Tacrolimus Ophthalmic Formulation for the Treatment of Ophthalmic Inflammatory Diseases. Barrieu M, Chennell P, Yessaad M, Bouattour Y, Wasiak M, Jouannet M, Le Basle Y, Sautou V. Pharmaceutics; 2022 Jan 04; 14(1):. PubMed ID: 35057013 [Abstract] [Full Text] [Related]
4. Quality by design approach for understanding the critical quality attributes of cyclosporine ophthalmic emulsion. Rahman Z, Xu X, Katragadda U, Krishnaiah YS, Yu L, Khan MA. Mol Pharm; 2014 Mar 03; 11(3):787-99. PubMed ID: 24423028 [Abstract] [Full Text] [Related]
5. Physicochemical and microbiological stability of insulin eye drops in an artificial tear vehicle used in the treatment of refractory neurotrophic keratopathy. Le Nguyen MH, Naoum MS, Andre C, Lethier L, Limat S, Fagnoni-Legat C, Guillaume Y, Gauthier AS. J Fr Ophtalmol; 2022 Oct 03; 45(8):860-871. PubMed ID: 35914962 [Abstract] [Full Text] [Related]
6. Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method. Kodym A, Wiśniewski A, Knioła D, Olejniczak M. Acta Pol Pharm; 2011 Oct 03; 68(4):555-64. PubMed ID: 21796938 [Abstract] [Full Text] [Related]
7. Stability of cyclosporine 1% in artificial tears. Fiscella RG, Le H, Lam TT, Labib S. J Ocul Pharmacol Ther; 1996 Oct 03; 12(1):1-4. PubMed ID: 8925391 [Abstract] [Full Text] [Related]
8. Stability of Ophthalmic Atropine Solutions for Child Myopia Control. Berton B, Chennell P, Yessaad M, Bouattour Y, Jouannet M, Wasiak M, Sautou V. Pharmaceutics; 2020 Aug 17; 12(8):. PubMed ID: 32824572 [Abstract] [Full Text] [Related]
9. [Translated article] Physicochemical and microbiological stability study of two new preservative-free methylprednisolone eye drops. Merino-Bohórquez V, Berisa-Prado S, Delgado-Valverde M, Tirado-Pérez MJ, García-Palomo M, Alonso-Herreros JM, Cañete-Ramírez C, Dávila-Pousa MD. Farm Hosp; 2024 Aug 17; 48(4):T145-T152. PubMed ID: 38782645 [Abstract] [Full Text] [Related]
10. Stability of extemporaneously prepared voriconazole ophthalmic solution. Al-Badriyeh D, Li J, Stewart K, Kong DC, Leung L, Davies GE, Fullinfaw R. Am J Health Syst Pharm; 2009 Aug 15; 66(16):1478-83. PubMed ID: 19667005 [Abstract] [Full Text] [Related]
11. Stability of ceftazidime in 1% and 5% buffered eye drops determined with HPLC method. Kodym A, Hapka-Zmich D, Gołab M, Gwizdala M. Acta Pol Pharm; 2011 Aug 15; 68(1):99-107. PubMed ID: 21485707 [Abstract] [Full Text] [Related]
12. Novel cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: a suitability study. Mondon K, Zeisser-Labouèbe M, Gurny R, Möller M. Eur J Pharm Biopharm; 2011 Jan 15; 77(1):56-65. PubMed ID: 20888909 [Abstract] [Full Text] [Related]
13. Stability of tacrolimus ophthalmic solution. Ezquer-Garin C, Ferriols-Lisart R, Alós-Almiñana M. Am J Health Syst Pharm; 2017 Jul 01; 74(13):1002-1006. PubMed ID: 28645998 [Abstract] [Full Text] [Related]
14. A water-soluble prodrug of cyclosporine A for ocular application: a stability study. Lallemand F, Perottet P, Felt-Baeyens O, Kloeti W, Philippoz F, Marfurt J, Besseghir K, Gurny R. Eur J Pharm Sci; 2005 Sep 01; 26(1):124-9. PubMed ID: 15978789 [Abstract] [Full Text] [Related]
15. Formulation and stability of an extemporaneous 0.02% chlorhexidine digluconate ophthalmic solution. Lin SC, Huang CF, Shen LJ, Wang HJ, Lin CY, Wu FL. J Formos Med Assoc; 2015 Dec 01; 114(12):1162-9. PubMed ID: 25260549 [Abstract] [Full Text] [Related]
16. Solubilization of Cyclosporine in Topical Ophthalmic Formulations: Preformulation Risk Assessment on a New Solid Form. Wu K, Gore A, Graham R, Meller R. J Pharm Sci; 2019 Oct 01; 108(10):3233-3239. PubMed ID: 31228492 [Abstract] [Full Text] [Related]
17. Self-assembling colloidal system for the ocular administration of cyclosporine A. Luschmann C, Tessmar J, Schoeberl S, Strauß O, Luschmann K, Goepferich A. Cornea; 2014 Jan 01; 33(1):77-81. PubMed ID: 24162754 [Abstract] [Full Text] [Related]
18. Physicochemical and microbiological stability study of two new preservative-free methylprednisolone eye drops. Merino-Bohórquez V, Berisa-Prado S, Delgado-Valverde M, Tirado-Pérez MJ, García-Palomo M, Alonso-Herreros JM, Cañete-Ramírez C, Dávila-Pousa MD, & Grupo de Trabajo de Farmacotecnia de la Sociedad Española de Farmacia Hospitalaria. Farm Hosp; 2024 Jan 01; 48(4):145-152. PubMed ID: 38570209 [Abstract] [Full Text] [Related]
19. Stability of cyclosporine in an extemporaneously compounded paste. Ghnassia LT, Yau DF, Kaye KI, Duggin GG. Am J Health Syst Pharm; 1995 Oct 15; 52(20):2204-7. PubMed ID: 8564591 [Abstract] [Full Text] [Related]
20. Physical and chemical properties and stability of sodium cefazolin in buffered eye drops determined with HPLC method. Kodym A, Bilski P, Domańska A, Hełminiak Ł, Jabłońska M, Jachymska A. Acta Pol Pharm; 2012 Oct 15; 69(1):95-105. PubMed ID: 22574512 [Abstract] [Full Text] [Related] Page: [Next] [New Search]